A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants

计划入组 84 人 · 首次发布于 2026 年 7 月 30 日

New Challenge Pool of Norwalk Virus Inoculum

计划入组 57 人 · 首次发布于 2005 年 8 月 30 日

Clinical Study of Oncolytic Virus in Glioblastoma

计划入组 20 人 · 首次发布于 2025 年 8 月 28 日

Ebola virus vaccine (Profectus Biosciences)

influenza virus vaccine

Measles virus vaccine live attenuated(M-M-R II, Proquad)

Assembly Biosciences

United States

AbbVie CDR (CAD Hedged)

United States

Enanta Pharmaceuticals

United States

WHO Declares Bundibugyo Virus Outbreak a Public Health Emergency, Adds First Diagnostic Test to EUL

Bundibugyo Ebola Outbreak in DRC and Uganda Declared Public Health Emergency of International Concern

Experimental mRNA Vaccine Shows Promise Against Three Ebola Virus Strains in Preclinical Studies